Uta Wagner

An antibody with high reactivity for disease-associated a-synuclein reveals extensive brain pathology Gabor G. KovacsUta WagnerBenoit DumontMaria PikkarainenAwad A. Osman • Nathalie StreichenbergerIrene LeisserJeremy VerchereThierry BaronIrina Alafuzoff •

H. Budka, I. Alafuzoff, M. Pikkarainen, 2012 .

An antibody with high reactivity for disease-associated α-synuclein reveals extensive brain pathology

H. Budka, I. Alafuzoff, M. Pikkarainen, 2012, Acta Neuropathologica.

Detection of disease-associated α-synuclein in the cerebrospinal fluid: a feasibility study

W. Pirker, G. Kovacs, I. Lachmann, 2014, Clinical neuropathology.

Quantification of human tissue transglutaminase by a luminescence sandwich enzyme-linked immunosorbent assay.

T. Mothes, A. Osman, I. Lachmann, 2011, Analytical biochemistry.

Immunoassay of in vitro activated human tissue transglutaminase.

T. Mothes, A. Osman, I. Lachmann, 2011, Analytical biochemistry.

Association of cerebrospinal fluid prion protein levels and the distinction between Alzheimer disease and Creutzfeldt-Jakob disease.

A. Vighetto, H. Struyfs, S. Engelborghs, 2015, JAMA neurology.

Sequence Variants of the CRH 5′‐Flanking Region

U. Wagner, C. Baerwald, O. Malysheva, 2006, Annals of the New York Academy of Sciences.

A caged Ab reveals an immediate/instructive effect of BDNF during hippocampal synaptic potentiation

T. Bonhoeffer, S. Cambridge, A. Kossel, 2001, Proceedings of the National Academy of Sciences of the United States of America.

Immunoassay of in vitro activated human tissue transglutaminase.

T. Mothes, A. Osman, I. Lachmann, 2011, Analytical biochemistry.